Role of diaphorase in intracellular activation of prodrugs in targeted chemotherapy of cancers
Kazan medical journal · 23.04.2026 · 107 (3) · 375-384
DOI: 10.17816/kmj698244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kazan medical journal, online erschienen am 23.04.2026. Verfasst von Vladimir N. Fedorov und 6 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Diaphorase (NQO1, NAD(P)H:quinone oxidoreductase 1) is an important biomarker of the presence and progression of cancer and also plays a key role in the activation of prodrugs used in targeted chemotherapy of tumors. This work aimed to compare data from long-term studies of the role of diaphorase in the intracellular activation of prodrugs used in targeted chemotherapy of oncologic diseases. The review includes data from relevant publications describing the biochemical functions of diaphorase, its role in oncology, and possibilities for increasing the effectiveness of antitumor therapy through induction of this enzyme. Articles published from 2000 to 2025 and indexed in the databases PubMed, ScienceDirect, and eLIBRARY.RU were analyzed. The study used methods of internet analysis, content analysis, and historical and descriptive-analytical approaches. Diaphorase accelerates the two-electron reduction of quinones to hydroquinones, preventing the formation of free radicals whereas simultaneously providing bioreductive activation of a number of cytotoxic drugs. Overexpression of diaphorase in malignant cells makes it possible to use this enzyme as a biocatalytic mechanism for selective delivery and activation of prodrugs, thereby increasing therapeutic effectiveness. The review examines modern enzyme–prodrug strategies, including ADEPT (Antibody-Directed Enzyme Prodrug Therapy), GDEPT (Gene-Directed Enzyme Prodrug Therapy), and PMT (Prodrug Monotherapy), as well as prospects for induction of diaphorase by compounds of the 1,2-dithiole-3-thione class and phytochemical agents. The relationship between NQO1 activity, mitochondrial dysfunction of tumor cells, and initiation of apoptosis is emphasized. Overall, diaphorase is considered a promising molecular target for the development of new bioreductive and mitochondria-targeted antitumor drugs.
Zitieren
APA
Fedorov, V. N., Vdovichenko, V. P., Korsakov, M. K., Romanycheva, A. A., Korovina, A. V., Arshinov, A. V., & Suleimanov, S. S. (2026). Role of diaphorase in intracellular activation of prodrugs in targeted chemotherapy of cancers. Kazan medical journal, 107(3), 375-384. https://doi.org/10.17816/kmj698244
Vancouver
Fedorov VN, Vdovichenko VP, Korsakov MK, Romanycheva AA, Korovina AV, Arshinov AV, et al. Role of diaphorase in intracellular activation of prodrugs in targeted chemotherapy of cancers. Kazan medical journal. 2026;107(3):375-384. doi:10.17816/kmj698244
BibTeX
@article{Fedorov2026,
author = {Fedorov, Vladimir N. and Vdovichenko, Vladimir P. and Korsakov, Michael K. and Romanycheva, Anna A. and Korovina, Alena V. and Arshinov, Andrej V. and Suleimanov, Salavat Sh.},
title = {Role of diaphorase in intracellular activation of prodrugs in targeted chemotherapy of cancers},
journal = {Kazan medical journal},
year = {2026},
volume = {107},
number = {3},
pages = {375--384},
doi = {10.17816/kmj698244}
}
EUVIMED